T1	Participants 709 783	22 rigorously selected cases were enrolled, 13 of whom completed the trial
T2	Participants 795 894	16-42 years of age and had newly acquired attention deficits persisting for 6-34 months post-injury
T3	Participants 346 403	treating attention deficits due to moderate-to-severe TBI
